Company profile · federal money
Affinergy, LLC
Affinergy, LLC received $0 in federal awards in FY2025 (down 100% from FY2024).
- FY2025 federal obligations
- $0
- FY2024
- $590.9K
Data through 2026-09-30; source: USAspending.gov.
Gathering everything on record…
From public government records, which may contain errors. Check the official source before relying on a number. Not financial, legal or investment advice. Terms · About the data
SBIR & STTR awards
75 small-business research awards (25 Phase II) worth $59.80M, 2005–2023.
- A novel peptide assay for hepcidin clinical monitoring Department of Health and Human Services · SBIR Phase II · $1.20M · 2023
- A Rapid Point of Care Test for APOL1 Renal Risk Alleles Department of Health and Human Services · SBIR Phase II · $1.43M · 2021
- Novel clinical assay to rapidly monitor posaconazole levels in plasma Department of Health and Human Services · SBIR Phase I · $294.5K · 2021
- Immunoprofiling to develop a novel diagnostic array for cardiac sarcoidosis Department of Health and Human Services · SBIR Phase I · $299.8K · 2020
- Rapid assay to monitor vancomycin levels at the point of care in hemodialysis patients Department of Health and Human Services · SBIR Phase II · $1.95M · 2020
All of its SBIR & STTR awards · SBA's SBIR.gov data